Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researchers Urge More Company-To-Company Collaboration On Clinical Trials

This article was originally published in The Gray Sheet

Executive Summary

With cost and time commitments ballooning for device and drug clinical development, some prominent researchers are pressing for companies with similar products to join together on new FDA pivotal trials rather than go it alone.

You may also be interested in...



Medtronic’s RAFT Keeps Hopes Afloat For Shift To CRT In Milder Heart Failure

Data reported last week could hasten moves by electrophysiologists to implant price-premium cardiac resynchronization therapy systems rather than conventional defibrillators in patients with earlier stage heart failure.

FDA Contributes Funds To Industry Post-Stenting Antiplatelet Trial

FDA is contributing $1.5 million to a large, collaborative clinical study designed to find out the optimum length of time to give anti-clotting drugs to patients with coronary drug-eluting stents

ECHA Deliberates On Final Microplastic Proposal As Beauty Industry’s Fate Hangs In Balance

A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.

Topics

UsernamePublicRestriction

Register

OM009163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel